Blood pressure control with active ultrafiltration measures and without antihypertensives is essential for survival in hemodiafiltration and hemodialysis programs for patients with CKD. A prospective observational study.

Between 60% of hemodialysis patients have hypervolemia. The present study hypothesizes that there is more notable survival in CKD patients whose hypertension can be controlled without antihypertensives and with ongoing dry weight reduction with the point-of-care dry weight (POC-DW) technique.
Blood pressure control with active ultrafiltration measures and without antihypertensives is essential for survival in hemodiafiltration and hemodialysis programs for patients with CKD. A prospective observational study.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

BioMed Central
BioMed Central BioMed Central

Blood pressure control with active ultrafiltration measures and without antihypertensives is essential for survival in hemodiafiltration and hemodialysis programs for patients with CKD: a prospective observational study - BMC Nephrology

Background High blood pressure is a prevalent condition in patients with chronic kidney disease on hemodialysis. Adequate control of high blood pressure is essential to reducing deaths in this group. The present study aimed to observe mortality prospectively in a group of patients in hemodialysis and hemodiafiltration programs in whom the use of antihypertensives was optimized with the point-of-care dry weight (POC-DW) technique. Methods The present observational, prospective study was carried out at the Pafram hemodiafiltration unit in Morona Santiago, Ecuador, and the hemodialysis unit of the Fundación Renal del Ecuador in Guayaquil, Ecuador, from August 2019 to December 2023. Patients who were receiving hemodiafiltration were included. Weight was optimized with POC-DW for eight weeks. In Group 1, patients whose use of antihypertensive drugs was not required to control systolic blood pressure with a value less than 150 mmHg predialysis, less than 130 mmHg postdialysis, and a peridialytic blood pressure (defined as post-HD minus pre-HD SBP) between 0 and − 20 mmHg were analyzed. In Group 2, patients who required antihypertensive drugs for not meeting the aims of systolic blood pressure were included. The variables included clinical, demographic, mortality, description of the treatment, and routine laboratory tests in dialysis programs. The sample was nonprobabilistic. Survival analysis was performed for the study groups. The log-rank test (Mantel-Cox) was used for survival comparisons. Results The study included 106 patients. Optimal blood pressure control without antihypertensive treatment was achieved in 52 patients (49.1%) (Group 1). In 54 patients (50.9%), antihypertensive agents were required (Group 2). There was more significant mortality in the group that received antihypertensives: 11 patients in group 1 (21.2%) versus 25 patients in group 2 (46.3%) (P = 0.005). Survival was more significant in group 1, with an HR of 2.2163 (1.125–4.158) (P = 0.0243). Conclusion In hemodiafiltration and hemodialysis programs, blood pressure control with active ultrafiltration measures and without using antihypertensives is essential for survival in patients with CKD.

The main finding confirms the hypothesis of the study that there is more remarkable survival in the group of patients with CKD whose hypertension can be controlled without antihypertensive treatment and with the use of constant dry weight reduction measures to optimize ultrafiltration. The factors associated with the lack of control of arterial hypertension were a history of vascular amputation, a history of being an ex-smoker, being a carrier of type 2 diabetes mellitus, having a serum ferritin level greater than 26.75%, being male, and being treated with hemodialysis. The associated protective factors were having a diagnosis of glomerulonephritis as an etiology of chronic kidney disease, a history of never smoking, a serum ALB concentration greater than 4.214 g/dl, effective blood flow greater than 423.5 ml/min, and interdialytic weight gain >4.925%, hemodiafiltration as treatment, urea levels less than 103.78 mg/dl, and fasting glucose levels less than 109.2 mg/dl. According to the time-adjusted model, only four factors were associated: age, transferrin saturation, serum albumin levels, and history of vascular amputation.

In the stratified analysis, differences in survival were demonstrated by the percentiles of blood pressure taken in the last month of survival or censoring. With blood pressures ranging from 141 mmHg to 122 mmHg, there is a proportional risk of death associated with the intake of antihypertensive agents. The same occurs when the blood pressure is less than 105 mmHg. These relationships could not be established with pressures greater than 141 mmHg.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Nephrology
Life Sciences > Health Sciences > Clinical Medicine > Nephrology
Haemodialysis
Life Sciences > Health Sciences > Clinical Medicine > Therapeutics > Renal replacement therapy > Haemodialysis
Mortality and Longevity
Humanities and Social Sciences > Society > Population and Demography > Mortality and Longevity
Risk Factors
Life Sciences > Health Sciences > Public Health > Health Promotion and Disease Prevention > Risk Factors
  • BMC Nephrology BMC Nephrology

    This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Your space to connect: The Cancer in understudied populations Hub

A new Communities’ space to connect, collaborate, and explore research on Cancers, Race and Ethnicity Studies and Mortality and Longevity!

Continue reading announcement

Related Collections

With Collections, you can get published faster and increase your visibility.

Lifestyle modifications for preventing kidney disease

BMC Nephrology invites new submissions on Lifestyle modifications for preventing kidney disease.

Chronic kidney disease (CKD) is a significant public health challenge, with lifestyle factors playing a crucial role in its prevention and management. Lifestyle modifications, including dietary changes, physical activity, weight management, and smoking cessation, have been identified as important strategies for reducing the risk of kidney disease and slowing its progression. Research in this area has highlighted the impact of lifestyle interventions on kidney health, emphasizing the potential for preventive measures to alleviate the burden of CKD.

Recent advances demonstrate the effectiveness of lifestyle interventions in reducing the risk of CKD and improving outcomes for individuals with kidney disease. Additionally, research has underscored the importance of multidisciplinary approaches that integrate lifestyle modifications into routine clinical care, promoting holistic kidney health.

Looking ahead, continued research in this area holds the potential for identifying personalized lifestyle interventions tailored to individual risk factors and cultural contexts. Furthermore, ongoing research efforts may lead to the development of innovative digital health tools and mobile applications that support individuals in adopting and sustaining healthy lifestyle behaviors to prevent kidney disease.

Topics of interest include, but are not limited to:

• Dietary interventions for kidney disease prevention

• Exercise and physical activity in CKD management

• Smoking cessation and its impact on kidney health

• Lifestyle modifications for reducing blood pressure and preventing CKD

• The role of mindfulness and stress reduction techniques in preventing kidney disease

• Impact of sleep quality and duration on kidney health

• Evaluating the effectiveness of community-based lifestyle interventions in preventing CKD

• Exploring the influence of socioeconomic factors on lifestyle modifications and kidney disease prevention

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Dec 12, 2025

Vascular control and renal blood flow regulation

BMC Nephrology is calling for submissions to our Collection on Vascular control and renal blood flow regulation.

This Collection aims to explore the intricate relationships between vascular control and renal blood flow regulation, highlighting current research and advancements in this critical area.

Advances in the field have significantly enhanced our understanding of renal vascular dynamics and their implications for various kidney disorders, such as hypertension, chronic kidney disease, and acute kidney injury. Recent studies have focused on the molecular pathways involved in renal perfusion regulation, including the role of nitric oxide, prostaglandins, and endothelial function. By unraveling these complex interactions, researchers have begun to develop novel therapeutic strategies aimed at improving renal blood flow and preventing renal injury, thereby enhancing patient outcomes.

Future research in this domain holds promise for identifying new biomarkers and therapeutic targets that can lead to more effective interventions for renal diseases. As our understanding of renal circulation deepens, it is likely that innovative approaches will emerge, such as personalized medicine strategies that account for individual variations in renal vascular responses. Additionally, advancements in imaging techniques and computational modeling may provide unprecedented insights into renal blood flow regulation, facilitating better clinical decision-making.

Topics of interest include, but are not limited to:

Mechanisms of renal blood flow regulation

Impact of renal vascular dynamics on kidney disease

Role of endothelial function in renal perfusion

Advances in renal circulation imaging

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Mar 19, 2026